AUM$320.5M
Expense Ratio0.35%
NAV$55.73
Holdings57
InceptionJun 19, 2006
Price Chart
Key Statistics
Previous Close
$55.49Day Range
$53.32$54.73
52-Week Range
$36.65$58.41
Avg Volume
76.5KDividend Yield
0.84%Expense Ratio
0.35%AUM
$320.5MShares Outstanding
4.0MSector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 94.94% |
| Ireland | 3.70% |
| Singapore | 1.29% |
| Other | 0.06% |
Fund Information
- Issuer
- SPDR
- Category
- Healthcare
- Subcategory
- Pharma
- Inception Date
- Jun 19, 2006
- Exchange
- NYSE_ARCA
- Description
- The State Street SPDR S&P Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index (the "Index")Seeks to provide exposure to the pharmaceuticals segment of the S&P TMI, which comprises the Pharmaceuticals sub-industrySeeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocksAllows investors to take strategic or tactical positions at a more targeted level than traditional sector based investing
Similar ETFs
The State Street SPDR S&P Pharmaceuticals ETF (XPH) is an exchange-traded fund issued by SPDR that launched on Jun 19, 2006. It currently manages $320.5M in assets under management. The fund charges an expense ratio of 0.35%. The fund holds 57 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 24.0% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | DFTX | DEFINIUM THERAPEUTICS INC | 2.99% | 493,617 | $9.5M |
| 2 | NKTR | NEKTAR THERAPEUTICS | 2.42% | 105,836 | $7.7M |
| 3 | EWTX | EDGEWISE THERAPEUTICS INC | 2.40% | 257,413 | $7.6M |
| 4 | VTRS | VIATRIS INC | 2.36% | 526,809 | $7.5M |
| 5 | RPRX | ROYALTY PHARMA PLC CL A | 2.33% | 159,723 | $7.4M |
| 6 | MRK | MERCK + CO. INC. | 2.33% | 62,599 | $7.4M |
| 7 | LQDA | LIQUIDIA CORP | 2.31% | 186,995 | $7.3M |
| 8 | JNJ | JOHNSON + JOHNSON | 2.29% | 29,588 | $7.3M |
| 9 | BMY | BRISTOL MYERS SQUIBB CO | 2.28% | 119,333 | $7.2M |
| 10 | PAHC | PHIBRO ANIMAL HEALTH CORP A | 2.28% | 142,153 | $7.2M |
| 11 | SUPN | SUPERNUS PHARMACEUTICALS INC | 2.26% | 132,387 | $7.1M |
| 12 | LGND | LIGAND PHARMACEUTICALS | 2.24% | 33,207 | $7.1M |
| 13 | MAZE | MAZE THERAPEUTICS INC | 2.22% | 137,068 | $7.0M |
| 14 | ELVN | ENLIVEN THERAPEUTICS INC | 2.21% | 230,490 | $7.0M |
| 15 | AMLX | AMYLYX PHARMACEUTICALS INC | 2.20% | 461,903 | $7.0M |
Page 1 of 2
Detailed Returns
| Period | Return | ETF | Cat. Avg | vs Avg |
|---|---|---|---|---|
| 1D | -3.17% | — | ||
| 1W | -1.98% | — | ||
| 1M | -3.76% | — | ||
| 3M | -1.35% | — | ||
| 6M | +20.63% | — | ||
| YTD | +0.51% | — | ||
| 1Y | +28.69% | — | ||
| 3Y | +35.11% | — | ||
| 5Y | +2.46% | — |
Moving Averages
20-Day MA
$56.78
Below 20-Day MA50-Day MA
$56.49
Below 50-Day MA200-Day MA
$49.22
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$58.41
Current Price
$53.73
52-Week Low
$36.65
$36.65$58.41
Current Yield
0.84%
Annual Dividend
$0.4648
Frequency
4x/year
Last Ex-Date
Dec 22, 2025
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Dec 22, 2025 | $0.1130 | Dec 24, 2025 |
| Sep 22, 2025 | $0.1026 | Sep 24, 2025 |
| Jun 23, 2025 | $0.0959 | Jun 25, 2025 |
| Mar 24, 2025 | $0.1533 | Mar 26, 2025 |
| Dec 23, 2024 | $0.1548 | Dec 26, 2024 |
| Sep 23, 2024 | $0.1947 | Sep 25, 2024 |
| Jun 24, 2024 | $0.1557 | Jun 26, 2024 |
| Mar 18, 2024 | $0.1730 | Mar 21, 2024 |
| Dec 18, 2023 | $0.1744 | Dec 21, 2023 |
| Sep 18, 2023 | $0.1201 | Sep 21, 2023 |
| Jun 20, 2023 | $0.1235 | Jun 23, 2023 |
| Mar 20, 2023 | $0.1154 | Mar 23, 2023 |
| Dec 19, 2022 | $0.1940 | Dec 22, 2022 |
| Sep 19, 2022 | $0.1320 | Sep 22, 2022 |
| Jun 21, 2022 | $0.1645 | Jun 24, 2022 |
| Mar 21, 2022 | $0.1811 | Mar 24, 2022 |
| Dec 20, 2021 | $0.1938 | Dec 23, 2021 |
| Sep 20, 2021 | $0.0892 | Sep 23, 2021 |
| Jun 21, 2021 | $0.0836 | Jun 24, 2021 |
| Mar 22, 2021 | $0.0725 | Mar 25, 2021 |
Dividend Payments Over Time
Category Comparison
| Metric | XPH | Healthcare(223 ETFs) | Pharma(11 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.35% | 0.60% | 0.67% |
| AUM | $320.5M | $1.25B | $288.5M |
| Dividend Yield | 0.84% | 2.75% | 1.02% |
| Avg Volume | 76.5K | 769.9K | 62.0K |
| Holdings | 57 | 182 | 38 |
| Performance | |||
| 1-Month Return | -2.63% | -3.02% | -2.77% |
| 6-Month Return | +16.40% | +5.85% | +19.05% |
| YTD Return | -0.93% | +0.17% | +2.36% |
| 1-Year Return | +26.60% | +16.65% | +22.62% |
Compare with Another ETF
Search for an ETF to compare with XPH: